PPAR𝛾 gene and atherosclerosis: Genetic polymorphisms, epigenetics and therapeutic implications
Atherosclerosis is the leading cause of mortality and morbidity in the developed world. It is characterized by the formation of a plaque in the walls of middle and large arteries leading to macrovascular complications. Several risk factors are included, with diabetes being one of the most important...
Main Authors: | Grbić E, Peterlin A, Kunej T, Petrovič D |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-10-01
|
Series: | Balkan Journal of Medical Genetics |
Subjects: | |
Online Access: | https://doi.org/10.2478/bjmg-2018-0011 |
Similar Items
-
Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 gene on lipid profile and adipokines levels in obese subjects
by: Becer E, et al.
Published: (2017-06-01) -
Dexmedetomidine ameliorates hyperalgesia of rat models with neuropathic pain via upregulation of PPAR-γ
by: ZHU Feng, ZHONG Yue, DENG Yijiang, LIU Wenzhi, BIAN Jiang
Published: (2023-09-01) -
LXRα is expressed at higher levels in healthy people compared to atherosclerosis patients and its over-expression polarizes macrophages towards an anti-inflammatory MΦ2 phenotype
by: Mengyuan Liu, et al.
Published: (2018-04-01) -
Relationship between PPAR‐γ gene polymorphisms and ischemic stroke risk: A meta‐analysis
by: Fan Cheng, et al.
Published: (2021-12-01) -
Niacin exacerbates β cell lipotoxicity in diet-induced obesity mice through upregulation of GPR109A and PPARγ2: Inhibition by incretin drugs
by: Xiaojing Zhang, et al.
Published: (2022-12-01)